Synthesis of 4-amino-3,5-dicyano-arylpyrazoles : part 2 : isolation and characterization of by-products by Gonçalves, M. Sameiro T. et al.
Address correspondence to M. S. T. Gonçalves, Chemistry Centre, University of Minho, Campus de Gualtar,  
4710-057 Braga, Portugal. Tel: + 351 253 604372. Fax: + 351 253 604386. E-mail: msameiro@quimica.uminho.pt 
      1 
  
SYNTHESIS OF 4-AMINO-3,5-DICYANO-ARYLPYRAZOLES. PART 2: ISOLATION 
AND CHARACTERIZATION OF BY-PRODUCTS 
 
M.S.T. Gonçalves*, A.M.F. Oliveira-Campos, L.M. Rodrigues and M.F.R.P. Proença 
Chemistry Centre, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal 
 
Abstract: Reaction of (dicyanomethylidene-hydrazino)benzoic acids  with chloroacetonitrile, under 
basic conditions, gave cyanomethyl-3-(7-amino-3,5-dicyano-1H-pyrazolo[4,3-d]pyrimidin-1-yl-
benzoates and para substituted cyanomethyl benzoates, in addition to the expected cyanomethyl 3-
(4-amino-3,5-dicyano-1H-pyrazol-1-yl)-benzoates. 
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INTRODUCTION 
Pyrazole derivatives are well recognised for their biological activities as potential HIV-1 inhibitors,
 
antiviral, anticancer agents, insecticides and fungicides.
[1-4] 
 
Pyrazole fused-heterocycles, namely pyrazolo[4,3-d]pyrimidine derivatives are also of great 
interest as potential biologically active molecules. Several members of this class exhibit recognised 
pharmacological activities for treatment of thromboembolic disorders, with affinity at adenosine 
receptors for the treatment of bronchoconstriction and cardiac insufficiency, as well as Hsp90 
inhibitory activity.
 [5-7] 
A classical method of pyrazole synthesis involves the reaction between hydrazines and -
difunctional compounds and it was applied to the preparation of 4-amino-1-phenyl-1H-pyrazole-
3,5-dicarbonitrile 1 (Figure 1).
[8] 
This methodology was initially used by our research group to 
2 
 
synthesise aminocyanopyrazoles containing a carboxylic ester group, such as compounds 2 (Figure 
1).
[9] 
Following this successful work, similar heterocyclic compounds 4 containing a cyano group  
in the pyrazole ring replacing the ethyl ester were obtained by the same route.
[10] 
(Scheme 1) The 
synthesis started by diazotisation of m-aminobenzoic acids and further reaction of the resulting 
diazonium salts with malononitrile giving (dicyanomethylidene-hydrazino)benzoic acids 3, which 
cyclised by treatment with chloroacetonitrile in DMF, triethylamine being used as the base.
[8]
 When 
the results obtained by heating the reaction mixtures at reflux for short periods (5–15 minutes) were 
compared to those of heating at 80–90 °C for longer times (1-4 hours), it was found that in some 
cases, the last procedure led to lower yields and this was attributed to possible decomposition (TLC) 
and/or formation of by-products which was not investigated at that point.  
 
<Figure 1> 
 
 As part of our research interest in the synthesis and study of pyrazoles and their related 
fused heterocycles,
[9-14]
 it was decided to reconsider the previously reported synthesis and use other 
bases, namely 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) and sodium hydride. The products were 
identified as the pyrazolo[4,3-d]pyrimidines 5, the para substituted cyanomethyl benzoates 6, and 
the expected pyrazoles 4.
[10]
 
 
RESULTS AND DISCUSSION  
3-[2-(Dicyanomethylene)hydrazinyl]-(5-(un)substituted)-benzoic acids 3, obtained by diazotisation 
of the corresponding aminobenzoic acids followed by reaction with malononitrile,
[10]
 were reacted 
with chloroacetonitrile in DMF using a non-nucleophilic organic base or an inorganic  base, namely 
DBU or sodium hydride, respectively (Scheme 1). After purification by column chromatography in 
silica gel, pyrazolo[4,3-d]pyrimidines 5, and para substituted cyanomethyl benzoates 6, were 
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isolated simultaneously with the expected pyrazoles 4, in variable yields, as shown in Table 1. The 
open chain ester, such as compound 7, was observed in all the experiments on TLC, but only 7a 
was quantitatively determined for the reaction from 3-[2-(dicyanomethylene)hydrazinyl]benzoic 
acid 3a. 
 
<Scheme 1> 
 
 Cyclisation of 3-[2-(dicyanomethylene)hydrazinyl]benzoic acid 3a using sodium hydride 
added stepwise gave the best yields for the pyrazoles 4a, and pyrazolo[4,3-d]pyrimidine 5a; and the 
cyanomethylester 7a was also  isolated (Table 1, entry 1). Starting from precursor 3b, and using the 
same base, pyrazolo[4,3-d]pyrimidine 5b was obtained in addition to the pyrazole 4b and the 
cyanomethyl ester 6b (Table 1, entry 3). 
When these reactions were repeated under the same conditions they were found not 
reproducible. Thus, it was decided to use DBU as the base when the yields of pyrazoles 4a and 4b 
were 17 and 21%, respectively (Table 1, entries 2 and 4).  
The cyclisation of 3c with DBU gave a low yield of the pyrazole 4c and this preparation was 
repeated for a shorter period with a minute improvement (Table 1, entries 5 and 6). Reaction under 
the same conditions with the methoxylated compound 3d gave the lowest yield and it was decided 
to repeat the reaction using a larger excess of base and no solvent which, however, gave a slight 
improvement only (Table 1, entries 7 and 8).  
<Table 1> 
 
Compounds 5 and 6 were fully characterised by high resolution mass spectrometry or 
elemental analysis, IR and NMR (
1
H and 
13
C) spectroscopy. Compounds 4 
[10]
 and 7a
[9]
 were 
described before. 
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The main feature on the 1H NMR spectra for pyrazolo[4,3-d]pyrimidines 5a-d is the 
position of the NH2 that moves to 7.41-7.45 (acetone-d6) or to 8.16-8.20 (DMSO-d6) ppm, as 
compared with 6.50-6.68 (DMSO-d6) (for 4a-d),
[10]
  while the remaining signals do not change 
significantly. Their EI mass spectra showed always a molecular ion that was 52 units higher than 
that of the corresponding aminopyrazoles 4a-d.
[10]
 In their EI mass spectra losses due to the ester 
side chain were observed together with ions due to loss of 52 (C2N2) or 53 (C2N2+H) that might 
result from cleavage on the pyrazole or pyrimidine moieties.  
 A detailed analysis of the 
13
C NMR data showed a set of signals which was very similar in 
both the corresponding aminopyrazole 4a-d
[10]
 and the new compound 5a-d, and this was assigned to 
the benzene nucleus. Three signals for cyano groups could be observed for all the compounds, for 
example for compound 5d they appear at 116.2, 115.1 and 116.0. 
The full assignment of 
13
C signals for compound 5d was carried out by bidimensional 
heteronuclear HMBC and HMQC correlation techniques and this allowed us to conclude that they 
would fit the proposed structure.  
 The IR spectra of these fused heterocycles 5a-d, as in the case of pyrazoles 4a-d,
[10]
 showed 
the expected bands, due to stretching vibrations of the cyano groups (2220-2250 cm
-1
), the amine 
(3225-3500 cm
-1
) and ester functions (1707-1735 cm
-1
), as well as a strong band of the C=N bond 
(1588-1643 cm
-1
) as result of  the heterocyclic ring. 
In most preparations a by-product identified as the para substituted cyanomethyl benzoate 6, 
was also isolated, and its 
1
H NMR spectrum was conclusive showing signals due to an aromatic 
ring containing two substituents in para position and a methylenic signal at about 5 ppm. Although 
the cyano absorption band was not present in the IR spectrum it is known that the intensity of such 
band may be very low.
[15]
 Therefore, and since the amounts obtained were minute, it was decided to 
prepare the esters 6c and 6d, by an independent method, from the corresponding benzoic acids and 
chloroacetonitrile. The 
1
H NMR showed two doublets in the aromatic region and the methylenic 
group at  4.89 (6c) or 4.93 (6d) ppm, but no cyano group was detected on their IR spectra. When 
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EI mass spectra were obtained, however, they showed the expected M
+
 ion, and also the base peak 
corresponding to loss of the fragment OCH2CN. For both compounds,
 13
C NMR spectra also 
showed a signal at  115.9 (6c) or 116.2 (6d) ppm, that was attributed to the cyano carbon. It is 
thought that these compounds are very prone to hydrolysis and this might explain why, to the 
knowledge of the authors, they were not reported in the literature before.  
In order to understand the pathway leading to compounds 4, 5 and 6, an NMR study was 
carried out on the evolution of compound 3, in DMF and in the presence of DBU and 
chloroacetonitrile. The starting material 3 (15 mg) was dissolved in DMF-d6 (0.5 mL) in an NMR 
tube, 2 equivalents of both chloroacetonitrile and DBU were added and the NMR spectra were 
registered after 30, 60, 90 and 120 minutes. The signals at  8.0-8.20, 7.53, 6.97, 6.70 and 6.53 ppm 
from compounds 6, 3, 5, hydrocyanic acid and 4, respectively, were followed to quantify the 
relative ratio of these materials in solution. The results obtained from this study are shown in Figure 
2. They indicate that the disappearance of the starting material originated mainly compound 4 and 
that compounds 5 and 6 were always present in a 1:1 molar ratio. After 30 minutes at room 
temperature, 9.6 % of 4, 2.4 % of hydrocyanic acid and 0.6 % of both 5 and 6 were identified in 
solution. After a period of 2 hours the reaction mixture still contained approximately 50% of the 
starting material 3, together with 22% of 4, 4.6 % of hydrocyanic acid, 10% of 6 and 10% of 5. This 
suggests that the major pathway leads to the formation of compound 4 from the reaction of 3 with 
chloroacetonitrile. The formation of 5 possibly results from the reaction between two molecules of 
4, eliminating hydrocyanic acid and the aromatic moiety 6. The compound mixture generated in the 
NMR study was separated by PLC, confirming the structure assignment to all the 
heterocyclic/aromatic products. 
<Figure 2> 
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EXPERIMENTAL 
Melting points were measured on a Gallenkamp melting-point apparatus and are 
uncorrected. IR spectra were registered on a Perkin Elmer FTIR-1600. UV spectra were determined 
on a Hitachi U-2000. NMR spectra were obtained on a Varian Unity Plus Spectrometer at an 
operating frequency of 300 MHz for 
1
H NMR and 75.4 MHz for 
13
C NMR or a Bruker Avance III 
400 at an operating frequency of 400 MHz for 
1
H NMR and 100.6 MHz for 
13
C NMR using the 
solvent peak as internal reference at 25 ºC. All chemical shifts are given in ppm using δH Me4Si = 0 
ppm as reference and J values are given in Hz. Assignments were made by comparison of chemical 
shifts, peak multiplicities and J values and were supported by spin decoupling-double resonance 
and bidimensional heteronuclear HMBC and HMQC correlation techniques.   
Low resolution EI mass spectra were determined on a Unicam GC-MS 120. High resolution 
mass spectra were obtained on a VG Ultima or AutoSpec E spectrometers. Elemental analyses were 
obtained on a Leco CHNS-932. TLC (Thin Layer Chromatography) and PLC (Preparative Layer 
Chromatography) were carried out on plates coated with silica gel 60 F254. Column chromatography 
was performed on silica gel (<230 mesh) with mixtures of light petroleum and diethyl ether of 
increasing polarity, unless other conditions are described. Light petroleum refers to the fraction 
boiling in the range 40-60 °C. 
 
General Procedures for the Cyclisation of Compounds 3a-d 
Method 1 
To a solution of the intermediate (3, 1 mequiv.) in dry DMF (1.6 mL), DBU (x mequiv.), and 
chloroacetonitrile (2.2 mequiv.) were added and the mixture was kept stirring at the temperature and 
time indicated in Table 1. After cooling the solvent was removed under reduced pressure and the 
dark oily mixture obtained was purified by column chromatography or PLC. 
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Method 2 
NaH (2.2 or 4.2 mequiv.) was suspended in DMF (2 mL) and a solution of the intermediate 
(1 mequiv.) in DMF (3 mL) was added slowly, with stirring. Chloroacetonitrile (2.2 mequiv.) was 
added and the mixture heated at the temperature and for the time mentioned in Table 1. 
After cooling, water was added, and then 6N HCl until a dark solid precipitated. This was 
filtered, dried in the oven (45 °C) and purified by chromatography. In some of the attempts only 
water was added and a brown oil separated which was extracted with acetone. The solvent was 
removed and the resulting oil was purified by column chromatography or PLC. 
 
Cyanomethyl 3-(7-amino-3,5-dicyano-1H-pyrazolo[4,3-d]pyrimidin-1-yl)benzoate 5a 
 After column chromatography, the pyrazolopyrimidine 5a was obtained as a yellow solid 
(21 %), mp 225.9-228.6 °C, IR (KBr, cm
-1
): 3500, 3317, 3225, 2960, 2920, 2232, 2220, 1732, 1633, 
1571; UV (EtOH): 230 nm (log  4.48), 260 nm (log  4.27), 375 nm (log 3.91); 1NMR (300 
MHz, DMSO-d6): 5.29 (2H, s, CH2), 7.84 (1H, t J 8.0 Hz, 5-H), 8.08 (1H, dt J 8.0 and 1.0 Hz, 4-H), 
8.25 (2H, br s, NH2), 8.42-8.48 (1H, m, 6-H), 8.61 (1H, t J 1.0 Hz, 2-H); 
13
CNMR (75.4 MHz, 
DMSO-d6): 50.12 (CH2), 111.5, 115.0 (CN), 115.8 (CN), 116.3 (CH2CN), 119.9, 122.2, 126.8, 
128.9, 129.3, 130.4, 130.6, 137.7, 143.8, 155.6 (C-7’), 163.9 (CO); m/z (%) (EI) 345 (M++1, 24), 
344 (M
+
, 100), 292 (M
+ 
- C2N2, 12), 288 (M
+ 
- OCH2CN, 87), 287 (21), 261 (11), 260 (M
+ 
- 
CO2CH2CN, 27), 208 (41), 207 (21), 206 (32), 181 (34), 144 (54), 129 (23), 119 (18), 116 (21), 103 
(23), 102 (52), 92 (30), 90 (22), 83 (16), 77 (22), 76 (31), 66 (24), 65 (33), 64 (99), 63 (49), 61 (52). 
Anal. calcd. for C16H8N8O2: C, 55.82; H, 2.33; N, 32.56 %. Found: C, 55.62; H, 2.5; N, 32.30 %. 
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Cyanomethyl 3-(7-amino-3,5-dicyano-1H-pyrazolo[4,3-d]pyrimidin-1-yl)-4-methylben-
zoate 5b 
 After column chromatography followed by washing with diethyl ether the 
pyrazolopyrimidine 5b was obtained as a yellow solid (32 %), mp 253.8-255.2 °C, IR (KBr, cm
-1
): 
3340, 3332, 3236, 2250, 2240, 1735, 1645, 1630, 1571; UV (EtOH): 230 nm (log  4.32)315 nm 
(log ), 375 nm (log ); 1H RMN (300 MHz, acetone-d6): 2.34 (3H, s, Me), 5.26 (2H, s, 
CH2), 7.45 (2H, br s, NH2), 7.76 (1H, d J 7.6 Hz, 5-H), 8.18-8.20 (1H, br s, 2-H), 8.22 (1H, dd J 7.6 
and 1.9 Hz, 6-H); 
13
CNMR (75.4 MHz, DMSO-d6): 17.7 (CH3), 49.9 (CH2), 115.0 (CN), 115.8 
(CN), 115.9 (CH2CN), 116.6, 119.6, 125.8, 126.7, 128.9, 130.9, 132.1, 142.2, 144.4, 155.8 (C-7’), 
163.5 (CO); m/z (EI) (%) 359 (M
+ 
+ 1, 22), 358 (M
+
, 91), 357 (24), 318 (M
+ 
- CH2CN, 47), 306 (M
+ 
- C2N2, 48), 305 (79), 302 (M
+ 
- OCH2CN, 17), 274 (M
+ 
- CO2CH2CN, 16), 273 (14), 239 (18), 222 
(40), 221 (19), 214 (38), 104 (21), 103 (53), 102 (24), 92 (35), 91 (33), 90 (45), 89 (100), 78 (45), 
77 (78), 76 (46). HRMS (EI): calcd for C17H10N8O2 [M
+
]: 358.0929; found: 358.0916. 
 
Cyanomethyl 3-(7-amino-3,5-dicyano-1H-pyrazolo[4,3-d]pyrimidin-1-yl)-4-chloroben-
zoate 5c 
After colunm chromatography followed by PLC, the pyrazolopyrimidine 5c was obtained as 
a yellow solid (4 or 10 %), mp 233.7-235.7 °C; IR (KBr, cm
-1
): 3454, 3343, 3250, 2241, 1733, 
1622, 1585, 1571, 1541; UV (EtOH): 230 nm (log  3.48)300 nm (log  3.45) nm, 375 (log  
3.78); 
1NMR (300 MHz, DMSO-d6): 5.22 (2H, s, CH2), 7.98 (1H, d J 8 Hz, 5-H), 8.16 (2H, br s, 
NH2), 8.20 (1H, dd J 8 and 2 Hz, 6-H), 8.31 (1H, d J 2 Hz, 2-H); 
13
CNMR (75.4 MHz, DMSO-d6): 
49.9 (CH2), 115.0 (CN), 115.5, 115.8 (CN), 116.5 (CH2CN), 120.3, 125.5, 131.3, 131.6, 133.0, 
134.0, 128.3, 137.1, 144.9, 156.0 (C-7’), 163.0 (CO); HRMS (EI): calcd for C16H7N8O2
35
Cl [M
+
]: 
378.0383; found: 378.0366. 
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Cyanomethyl 3-(7-amino-3,5-dicyano-1H-pyrazolo[4,3-d]pyrimidin-1-yl)-4-methoxy-
benzoate 5d 
 After column chromatography followed by PLC, the pyrazolopyrimidine 5d was obtained 
as a yellow solid (2 or 10 %), that decomposes at 200 °C without melting; IR (KBr, cm
-1
): 3473, 
3366, 2242, 2228, 1707; UV (EtOH): 234 nm (log  4.41) 308 nm (log  3.70) nm, 374 nm (log  
3.98);  
1NMR (400 MHz, DMSO-d6): 3.87 (3H, s, OCH3), 5.21 (2H, s, CH2), 7.49 (1H, d J 8.8 
Hz, 5-H), 8.06 (2H, br s, NH2), 8.13 (1H, d J 2 Hz, 2-H), 8.23 (1H, dd J 8.8 and 2.4 Hz, 6-H); 
13
CNMR (100.6 MHz, DMSO-d6): 49.9 (CH2), 56.8 (OCH3), 113.5 (C-5), 115.1 (CN), 116.0 (CN), 
116.2 (CH2CN), 119.6 (C-3’ or C-7’a), 120.3 (C-1), 124.7 (C-3), 125.5 (C-3’ or C-7’a), 130.8 (C-
2), 133.9 (C-6), 144.8 (C-5’), 155.9 (C-7’), 159.3 (C-4), 163.4 (CO); HRMS (EI): calcd for 
C17H10N8O3 [M
+
]: 374.087586; found: 374.086754.
 
 
Esters 6 as obtained during the preparation of pyrazoles 4. 
Cyanomethyl 4-methylbenzoate 6b 
After PLC the ester 6b was obtained as an oil (6 %); IR (neat) (cm
-1
): 2921, 2838, 1729, 
1612; 
1NMR (300 MHz, CDCl3): 2.45 (3H, s, CH3), 4.97 (2H, s, CH2), 7.30 (2H, d J 8.2 Hz, 3-H 
and 5-H), 7.96 (2H, d J 8.2 Hz, 2-H and 6-H); m/z (%) (EI) 175 (M
+
, 14), 120 (9), 119 (M
+ 
- 
OCH2CN, 100), 91 (39), 89 (10), 65 (4). 
 
Cyanomethyl 4-chlorobenzoate 6c 
After column chromatography followed by PLC, ester 6c was obtained as a white oil that 
later solidified (18 %); the experimental data confirmed its structure and were in accordance with 
those described below obtained in an independent synthesis. 
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Cyanomethyl 4-methoxybenzoate 6d 
  After column chromatography and PLC, the ester 6d was obtained as a colourless oil that 
later solidified (3 %), mp 58.9-59.7 °C; the experimental data confirmed its structure and were in 
accordance with those described below obtained in an independent synthesis. 
 
Synthesis of the esters 6c and 6d. 
Cyanomethyl 4-chlorobenzoate 6c 
To a solution of p-chlorobenzoic acid (0.5 g, 3.2 mequiv.) in dry DMF (3 mL), potassium 
carbonate (0.44 g, 3.2 mequiv.) and chloroacetonitrile (0.2 mL, 3.2 mequiv.) were added and the 
mixture was kept stirring overnight. Water was added and the mixture was extracted with ether. The 
organic extracts were dried (MgSO4) and the solvent removed to give ester 6c as an oil which later 
solidified (0.41 g, 65 %), mp 48.5-50.3 °C; IR (neat, cm
-1
): 3455, 2943, 1736, 1670, 1589; 
1NMR 
(300 MHz, CDCl3): 4.89 (2H, s, CH2), 7.27 (2H, d J 9Hz, 3 and 5-H) 7.80 (2H, d J 9Hz, 2 and 6-
H). 
13
CNMR (75.4 MHz, DMSO-d6): 50.0 (CH2), 115.9 (CN), 126.8 (C-1), 129.2 (C-3 and C-5), 
131.3 (C-2 and C-6), 139.2 (C-4), 163.9 (C=O); m/z (%) (EI) 197 (M
+
, 
37
Cl, 30), 195 (M
+
, 
35
Cl, 84), 
141 (34), 139 (100), 113 (24), 111 (72), 76 (19), 75 (57), 74 (26). Anal. calcd. for C9H6NO2Cl: C, 
55.26; H, 3.09; N, 7.16 %. Found: C, 55.50; H, 3.05; N, 7.15. 
 
Cyanomethyl 4-methoxybenzoate 6d 
Following the method just described for 6c and using p-methoxybenzoic acid, the ester 6d 
was obtained as a reddish brown solid (79 %), mp 60.2-62.0 °C; IR (KBr, cm
-1
): 3426, 3014, 2972, 
2939, 2844, 1916, 1724, 1608, 1580, 1513; 
1NMR (300 MHz, DMSO-d6): 3.84 (3H, s, OCH3), 
5.17 (2H, s, CH2), 7.09 (2H, dd J 6.1 and 2.1 Hz, 3-H and 5-H), 7.95 (2H, dd J 6.9 and 2.1 Hz, 2-H 
and 6-H); 
13
CNMR (75.4 MHz, DMSO-d6): 49.5 (CH2), 55.7 (OCH3), 114.4 (C-3 and C-5), 116.2 
(CN), 120.0 (C-1), 131.8 (C-2 and C-6), 163.9 (C-4), 164.3 (CO); m/z (EI) (%) 192 (M
+ 
+ 1, 8), 191 
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(M
+
, 57), 136 (10), 135 (M
+ 
-  OCH2CN, 100), 107 (14), 92 (29), 77 (13), 64 (6). HRMS (EI): calcd 
for C10H19NO3 [M
+
]: 191.058243; found: 191.058294. 
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TABLES 
Table 1. 
 Starting 
material 
Time (h)/ 
Temp. (ºC)
a
 
Base 
(mequiv.) 
Product yield (%) 
Entry 4 5 6 7 
1 3a 5/80+10/100 NaH (4.2)
c
 54 21 --- 3 
2 3a
b
 10 DBU (2.2) 17 -- -- 3 
3 3b 5/80+10/100 NaH (4.2)
c
 16 32 6 --- 
4 3b 10 DBU (2.2) 21 --- --- --- 
5 3c 10 DBU (2.2) 6 10 18 --- 
6 3c 2 DBU (2.2) 11 4 --- --- 
7 3d 2 DBU (2.2) 2 10 --- --- 
8 3d
d 
5 DBU (6.0) 14 2 3 --- 
 
a
 The reaction temperature was 100-120 ºC except when otherwise stated 
b
 Similar result was obtained when the reaction was carried out under N2 
c
 Stepwise addition of base 
d
 Reaction carried out without solvent 
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FIGURES 
 
Figure 1. 
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1 R = R1 = H, R2 = CN
2 R = CO2CH2CO2Et, R
1 = Me, OMe, Cl, R2 = CO2Et
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Figure 2. 
 Concentration (%) of compounds 
t (min) 3d HCN 6d 5d 4d 
0 100 0 0 0 0 
30 87 2.4 0.6 0.6 9.6 
60 72 4.3 5.6 5.6 12.5 
90 63 4.1 8.2 8.2 18.5 
120 53 4.6 10 10 22 
17 
 
SCHEMES 
 
Scheme 1.  
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LEGENDS 
 
Table 1. Experimental conditions, and yields for the synthesis of pyrazoles 4 (chloroacetonitrile, 2.2 
mequiv., was used in all reactions). 
 
Figure 1. Structure of pyrazoles 1 and 2. 
Figure 2. NMR study of the evolution of 3d in DMF with DBU and chloroacetonitrile  
Scheme 1. Synthesis of pyrazoles 4 and their secondary products. 
 
 
 
 
 
 
 
 
 
 
 
 
 
